| Home |
| Current Issue |
| Past Issues |
| Sample Articles |
| SANUM |
| Article Summaries |
| Subscription Info |
| Contact Us |
| Calendar |
| Links |
| Sponsors |
SANUM Pharmaceuticals, The PLEO™ SAN Sanukehl Preparations Polysaccharides for Haptenic Therapy(This is the first in a new series of articles on PLEO™ SAN (Sanukehl Hapten) preparations in Explore! for the Professional.)
(Explore Issue: Volume 10, Number 1)Introduction
For many diseases, a pathogen's toxins can still be present after the germ itself has been eliminated, thus perpetuating the disease. In fact, the toxins might be the sole disease-causing agent. To protect themselves from their own toxins, pathogens produce specific polysaccharides (termed antigen absorbers by CORNELIUS) designed to bind the pathogen's own toxins or antigens, preventing them from becoming active. Moreover, viruses, bacteria, plants and animals know how to store and communicate information with the aid of saccharides. The code laid down in this language is thus able to influence a multitude of regulatory processes in the host organism.
Furthermore, the low-molecular-weight polysaccharides represent haptens, which -- when coupled to a higher-molecular-weight carrier (e.g., protein) -- can stimulate cellular and humoral defenses. Bacterial toxins released during earlier infections and not eliminated from the body due to immune-system deficiencies can be bound by haptens, and thus represent an antigen. This antigen is capable of stimulating the immune system by activating the T lymphocytes, ultimately leading to elimination of the bacterial toxins.
Production of PLEO™ SANS
The initial materials for the various PLEO™ SANS are dead cells of the corresponding bacterial or fungal types. Using a painstaking extraction process, the polysaccharides necessary for haptenic therapy are dissolved out of the organism's cell walls. Due to differences in the fine structure of these polysaccharides in each bacterial or fungal type, this results in a large number of antigen variations.
In the extractions process, the polysaccharides are separated out from undesired proteins, as well as from lipid A, which is also a cell-wall component in gram-negative bacteria. The proteins could trigger an allergic reaction, while lipid A is responsible for the toxic effect of the lipopolysaccharides (endotoxins) of gram-negative bacteria.
Polysaccharides from microorganisms are nontoxic to the host organism. For haptenic therapy with PLEO™ SANS, the extracted polysaccharide extract is homeopathically potentiated; the end result is largely free of proteins and endotoxins. Therefore, allergic and fever reactions due to the use of PLEO™ SANS are unlikely.
